Approval · Notice of Compliance 32284 · 2023
ZEVALIN: Notice of Compliance 32284
Issued November 17, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32284
- Date
- November 17, 2023
- Company
- Auro Pharma Inc.Woodbridge, Ontario, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Administrative - Administrative Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZEVALIN | 02328674 | Approved |
Medicinal ingredients
- IBRITUMOMAB TIUXETAN 1.6 MG per ML